Financials

News Discussions Technicals Forecast Seasonals

BKGI fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Bangkok Genomics Innovation PCL engages in the provision of screening services for fetal chromosomal abnormalities. It offers screening for genetic abnormalities, analysis infectious disease group, cancer related screening, genetic code analysis with whole exome sequencing, individual genetic testing, newborn screening, basic health check-up, providing technology services and other medical products. The company was founded in 2017 and is headquartered in Bangkok, Thailand.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

BKGI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company